Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

LUVIANCA J FONSECA

Allopathic & Osteopathic Physicians Family Medicine

NPI
1205824406
CMS profile
191232
Location
CHICAGO, IL

General Payments · PY2018–2024

$6,203.24

  • Reported across 359 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$736.84

35 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $736.84 35

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Lilly USA, LLC $302.34 13
Seqirus USA Inc $76.76 4
Exact Sciences Corporation $72.90 3
Acerta Pharma LLC $56.21 3
Novo Nordisk AS $50.30 3
ABBVIE INC. $48.68 3
PFIZER INC. $30.16 2
Astellas Pharma US Inc $29.74 1
Boehringer Ingelheim Pharmaceuticals, Inc. $28.23 1
GlaxoSmithKline, LLC. $25.95 1
Amgen Inc. $15.57 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,089.29 84
PY2019 $915.97 57
PY2020 $933.72 56
PY2021 $1,045.35 55
PY2022 $712.75 37
PY2023 $769.32 35
PY2024 $736.84 35

Payment records · PY2024 (35)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $16.17 02/06/2024 Food and Beverage Undisputed 01/23/2026 1103741017 CMS
ABBVIE INC. $16.51 06/13/2024 Food and Beverage Undisputed 01/23/2026 1103741019 CMS
ABBVIE INC. $16.00 10/03/2024 Food and Beverage Undisputed 01/23/2026 1103741021 CMS
Amgen Inc. $15.57 10/24/2024 Food and Beverage Undisputed 01/23/2026 1111576106 CMS
Astellas Pharma US Inc $29.74 03/20/2024 Food and Beverage Undisputed 01/23/2026 1139301954 CMS
AstraZeneca Pharmaceuticals LP $15.95 01/30/2024 Food and Beverage Undisputed 01/23/2026 1104664149 CMS
AstraZeneca Pharmaceuticals LP $20.90 05/21/2024 Food and Beverage Undisputed 01/23/2026 1105674183 CMS
AstraZeneca Pharmaceuticals LP $19.36 06/24/2024 Food and Beverage Undisputed 01/23/2026 1104605304 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $28.23 07/02/2024 Food and Beverage Undisputed 01/23/2026 1117915711 CMS
Exact Sciences Corporation $24.89 07/29/2024 Food and Beverage Undisputed 01/23/2026 1114660120 CMS
Exact Sciences Corporation $24.89 09/26/2024 Food and Beverage Undisputed 01/23/2026 1114660126 CMS
Exact Sciences Corporation $23.12 11/08/2024 Food and Beverage Undisputed 01/23/2026 1114660132 CMS
GlaxoSmithKline, LLC. $25.95 04/22/2024 Food and Beverage Undisputed 01/23/2026 1116629922 CMS
Lilly USA, LLC $19.82 01/16/2024 Food and Beverage Undisputed 01/23/2026 1135160978 CMS
Lilly USA, LLC $24.65 02/04/2024 Food and Beverage Undisputed 01/23/2026 1135161495 CMS
Lilly USA, LLC $24.20 02/28/2024 Food and Beverage Undisputed 01/23/2026 1135140824 CMS
Lilly USA, LLC $26.74 03/18/2024 Food and Beverage Undisputed 01/23/2026 1135098606 CMS
Lilly USA, LLC $22.78 03/26/2024 Food and Beverage Undisputed 01/23/2026 1135161497 CMS
Lilly USA, LLC $21.19 04/23/2024 Food and Beverage Undisputed 01/23/2026 1135140826 CMS
Lilly USA, LLC $23.24 05/05/2024 Food and Beverage Undisputed 01/23/2026 1135140828 CMS
Lilly USA, LLC $20.34 05/22/2024 Food and Beverage Undisputed 01/23/2026 1135150494 CMS
Lilly USA, LLC $14.80 06/11/2024 Food and Beverage Undisputed 01/23/2026 1135161499 CMS
Lilly USA, LLC $24.86 06/25/2024 Food and Beverage Undisputed 01/23/2026 1135150496 CMS
Lilly USA, LLC $26.42 07/30/2024 Food and Beverage Undisputed 01/23/2026 1135161501 CMS
Lilly USA, LLC $25.08 08/13/2024 Food and Beverage Undisputed 01/23/2026 1135160980 CMS
Lilly USA, LLC $28.22 09/17/2024 Food and Beverage Undisputed 01/23/2026 1135159117 CMS
Novo Nordisk Inc $21.53 02/12/2024 Food and Beverage Undisputed 01/23/2026 1096747544 CMS
Novo Nordisk Inc $13.90 03/20/2024 Food and Beverage Undisputed 01/23/2026 1096580215 CMS
Novo Nordisk Inc $14.87 04/25/2024 Food and Beverage Undisputed 01/23/2026 1096584979 CMS
PFIZER INC. $14.24 03/05/2024 Food and Beverage Undisputed 01/23/2026 1131276210 CMS
PFIZER INC. $15.92 10/02/2024 Food and Beverage Undisputed 01/23/2026 1132115517 CMS
Seqirus USA Inc $19.91 01/29/2024 Food and Beverage Undisputed 01/23/2026 1125638220 CMS
Seqirus USA Inc $20.10 03/11/2024 Food and Beverage Undisputed 01/23/2026 1125638226 CMS
Seqirus USA Inc $15.31 06/06/2024 Food and Beverage Undisputed 01/23/2026 1125638230 CMS
Seqirus USA Inc $21.44 10/18/2024 Food and Beverage Undisputed 01/23/2026 1125638240 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.